Enovis (ENOV) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -2,414.00 |
| Dec 31, 2025 | -594.00 |
| Oct 3, 2025 | -75.00 |
| Jul 4, 2025 | -225.00 |
| Apr 4, 2025 | -1,110.00 |
| Dec 31, 2024 | 174.00 |
| Sep 27, 2024 | -176.00 |
| Jun 28, 2024 | -1,077.00 |
| Mar 29, 2024 | -3.00 |
| Dec 31, 2023 | -783.00 |
| Sep 29, 2023 | -891.00 |
| Jun 30, 2023 | -606.00 |
| Mar 31, 2023 | -308.00 |
| Dec 31, 2022 | -2,604.00 |
| Sep 30, 2022 | -111.00 |
| Jul 1, 2022 | -1,738.00 |
| Apr 1, 2022 | -1,417.00 |
| Dec 31, 2021 | 123.00 |
| Oct 1, 2021 | 1,512.00 |
| Jul 2, 2021 | 1,270.00 |
| Apr 2, 2021 | 1,922.00 |
| Dec 31, 2020 | 75.00 |
| Oct 2, 2020 | -126.00 |
| Jul 3, 2020 | -317.00 |
| Apr 3, 2020 | 453.00 |
| Dec 31, 2019 | -864.00 |
| Sep 27, 2019 | -1,044.00 |
| Jun 28, 2019 | -147.00 |
| Mar 29, 2019 | -658.00 |
| Dec 31, 2018 | 351.00 |
| Sep 28, 2018 | 140.00 |
| Jun 29, 2018 | -355.00 |
| Mar 30, 2018 | 73.00 |
| Dec 31, 2017 | -539.00 |
| Sep 29, 2017 | -166.00 |
| Jun 30, 2017 | -28.00 |
| Mar 31, 2017 | 1,837.00 |
| Dec 31, 2016 | 814.00 |
| Sep 30, 2016 | -142.00 |
| Jul 1, 2016 | -725.00 |
| Apr 1, 2016 | -104.00 |
| Dec 31, 2015 | -327.00 |
| Sep 25, 2015 | 429.00 |